A Synthetic MVA-based SARS-CoV-2 Vaccine, GEO-CM04S1, for the Prevention of COVID-19 Infection

Clinical trial NCT04639466 · COMPLETED

Trial details

NCT number: NCT04639466
Sponsor: GeoVax, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

COVID-19 Infection

Start date: 2020-11-19
Primary completion: 2025-10-31
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.